SCHEMBL31361669

SCHEMBL31361669

CC(C)(C)OC(=O)N1CCO[C@@H](Cn2cc(N)cn2)C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHA2 P29317 4/20 0.43
ERBB2 P04626 1/20 0.41
EPHB4 P54760 1/20 0.41
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RECQL P46063 1/20 0.39
GPR119 Q8TDV5 2/20 0.37
P2RX3 P56373 3/20 0.37
P2RX2 Q9UBL9 3/20 0.37
SCD O00767 1/20 0.36
SCD5 Q86SK9 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
NR1H2 P55055 1/20 0.36
LMNA P02545 1/20 0.36
USP30 Q70CQ3 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16652473 1.00 EPHA2 (0.43) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16652472 1.00 EPHA2 (0.43) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16876582 0.88 EPHA2 (0.46) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16876583 0.88 EPHA2 (0.46) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16885204 0.88 EPHA2 (0.46) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL31361644 0.85 MAPT (0.42) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16652730 0.85 MAPT (0.42) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16652728 0.85 MAPT (0.42) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL31361640 0.85 MAPT (0.42) EPHA2ERBB2EPHB4USP2SMN1; SMN2
SCHEMBL16652295 0.83 USP30 (0.48) EPHA2ERBB2EPHB4USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025017116-A1 PHARMACEUTICAL COMPOUNDS HAVING ACTIVITY AS WEE1 INHIBITORS SENTINEL ONCOLOGY LIMITED (GB) 2025-01-23 WO disclosed